- Laboratory Corporation of America (NYSE:LH) Q3 results ($M): Total Revenues: 2,372.7 (+4.5%); Diagnostics: 1,671.8 (+4.4%); Covance: 701.1 (+4.8%).
- Net Income: 179.5 (+16.0%); EPS: 1.71 (+14.0%); Non-GAAP EPS: 2.25 (+8.7%); CF Ops: 249.9 (-13.2%).
- 2016 Guidance: Total Revenue Growth: 10.0 - 11.0% from 9.5 - 10.5%; Diagnostics Revenue Growth: 5.0 - 6.0% from 4.5 - 5.5%; Covance Revenue Growth: 7.5 - 9.0% from 7.0 - 9.0%; Non-GAAP EPS: $8.70 - 8.90 from $8.60 - 8.95; FCF: $840M - 880M from $900M - 950M.
LabCorp Q3 revenues up 5%; net income up 16%; cash flow ops down 13%
Recommended For You
About LH Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LH | - | - |
Laboratory Corporation of America Holdings |